Cargando…

Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.

The aim of the present study was to compare the effects of selective phosphodiesterase (PDE) 3, 4 and 5 inhibitors on antigen-induced airway hyperresponsiveness in sensitized guinea-pigs. When the sensitized guinea-pigs were orally pre-treated with the selective PDE4 inhibitor, Ro 20-1724 (30 mg/kg)...

Descripción completa

Detalles Bibliográficos
Autores principales: Germain, N, Boichot, E, Planquois, J M, Lagente, V
Formato: Texto
Lenguaje:English
Publicado: 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781799/
https://www.ncbi.nlm.nih.gov/pubmed/10704053
_version_ 1782131975057833984
author Germain, N
Boichot, E
Planquois, J M
Lagente, V
author_facet Germain, N
Boichot, E
Planquois, J M
Lagente, V
author_sort Germain, N
collection PubMed
description The aim of the present study was to compare the effects of selective phosphodiesterase (PDE) 3, 4 and 5 inhibitors on antigen-induced airway hyperresponsiveness in sensitized guinea-pigs. When the sensitized guinea-pigs were orally pre-treated with the selective PDE4 inhibitor, Ro 20-1724 (30 mg/kg), and studied 48h after OA, a significant reduction (P<0.01) of the leftward shift of the dose-response curve to ACh was noted, whereas it was ineffective at the lower dose (10 mg/kg). Administration of the selective PDE3 inhibitor, milrinone (30 mg/kg) also elicited a significant reduction (P<0.01) of the airway hyperresponsiveness, whereas the PDE5 inhibitor zaprinast (30 mg/kg) was ineffective. These results show that both PDE3 and PDE4 inhibitors are able to inhibit the antigen-induced airway hyperresponsiveness in sensitized guinea-pigs and support the potential utility of selective PDE inhibitors in the treatment of asthma.
format Text
id pubmed-1781799
institution National Center for Biotechnology Information
language English
publishDate 1999
record_format MEDLINE/PubMed
spelling pubmed-17817992007-01-25 Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs. Germain, N Boichot, E Planquois, J M Lagente, V Mediators Inflamm Research Article The aim of the present study was to compare the effects of selective phosphodiesterase (PDE) 3, 4 and 5 inhibitors on antigen-induced airway hyperresponsiveness in sensitized guinea-pigs. When the sensitized guinea-pigs were orally pre-treated with the selective PDE4 inhibitor, Ro 20-1724 (30 mg/kg), and studied 48h after OA, a significant reduction (P<0.01) of the leftward shift of the dose-response curve to ACh was noted, whereas it was ineffective at the lower dose (10 mg/kg). Administration of the selective PDE3 inhibitor, milrinone (30 mg/kg) also elicited a significant reduction (P<0.01) of the airway hyperresponsiveness, whereas the PDE5 inhibitor zaprinast (30 mg/kg) was ineffective. These results show that both PDE3 and PDE4 inhibitors are able to inhibit the antigen-induced airway hyperresponsiveness in sensitized guinea-pigs and support the potential utility of selective PDE inhibitors in the treatment of asthma. 1999 /pmc/articles/PMC1781799/ /pubmed/10704053 Text en
spellingShingle Research Article
Germain, N
Boichot, E
Planquois, J M
Lagente, V
Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.
title Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.
title_full Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.
title_fullStr Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.
title_full_unstemmed Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.
title_short Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.
title_sort reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781799/
https://www.ncbi.nlm.nih.gov/pubmed/10704053
work_keys_str_mv AT germainn reducedairwayhyperresponsivenessbyphosphodiesterase3and4inhibitorsinguineapigs
AT boichote reducedairwayhyperresponsivenessbyphosphodiesterase3and4inhibitorsinguineapigs
AT planquoisjm reducedairwayhyperresponsivenessbyphosphodiesterase3and4inhibitorsinguineapigs
AT lagentev reducedairwayhyperresponsivenessbyphosphodiesterase3and4inhibitorsinguineapigs